111 related articles for article (PubMed ID: 33690095)
1. Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice.
Li Y; Xue H; Fang S; Wang G; Wang Y; Wang T; Shi R; Wu J; Ma Y
J Pharm Biomed Anal; 2021 May; 198():113986. PubMed ID: 33690095
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis of cholestatic liver damage in mice.
Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis.
Furuya S; Argemi J; Uehara T; Katou Y; Fouts DE; Schnabl B; Dubuquoy L; Belorkar A; Vadigepalli R; Kono H; Bataller R; Rusyn I
Alcohol Clin Exp Res; 2020 Jan; 44(1):87-101. PubMed ID: 31710124
[TBL] [Abstract][Full Text] [Related]
4. CsHscB Derived from a Liver Fluke
Yu Q; Koda S; Xu N; Li J; Wang JL; Liu M; Liu JX; Zhang Y; Yang HM; Zhang BB; Li XY; Li XC; Tang RX; Zheng KY; Yan C
Curr Mol Med; 2024; 24(4):505-515. PubMed ID: 37076961
[TBL] [Abstract][Full Text] [Related]
5. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
Zhang Y; Xu N; Xu J; Kong B; Copple B; Guo GL; Wang L
Hepatology; 2014 Sep; 60(3):919-30. PubMed ID: 24619556
[TBL] [Abstract][Full Text] [Related]
6. Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis.
Zheng S; Cao P; Yin Z; Wang X; Chen Y; Yu M; Xu B; Liao C; Duan Y; Zhang S; Han J; Yang X
Food Funct; 2021 Mar; 12(5):2323-2334. PubMed ID: 33620063
[TBL] [Abstract][Full Text] [Related]
7. Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
[TBL] [Abstract][Full Text] [Related]
9. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
[TBL] [Abstract][Full Text] [Related]
10. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
Pose E; Sancho-Bru P; Coll M
Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology.
Fu K; Dai S; Li Y; Ma C; Xue X; Zhang S; Wang C; Zhou H; Zhang Y; Li Y
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166822. PubMed ID: 37523877
[TBL] [Abstract][Full Text] [Related]
12. Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.
Zhou Y; Xu M; Liu P; Liang B; Qian M; Wang H; Song X; Nyshadham P; Che L; Calvisi DF; Li F; Lin S; Chen X
Am J Pathol; 2020 Jul; 190(7):1414-1426. PubMed ID: 32275903
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
[TBL] [Abstract][Full Text] [Related]
14. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
[TBL] [Abstract][Full Text] [Related]
15. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
[TBL] [Abstract][Full Text] [Related]
16. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Kimura M; Nishikawa K; Osawa Y; Imamura J; Yamaji K; Harada K; Yatsuhashi H; Murata K; Miura K; Tanaka A; Kanto T; Kohara M; Kamisawa T; Kimura K
Hepatol Commun; 2022 Oct; 6(10):2732-2747. PubMed ID: 35855613
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.
Pandey V; Sultan M; Kashofer K; Ralser M; Amstislavskiy V; Starmann J; Osprian I; Grimm C; Hache H; Yaspo ML; Sültmann H; Trauner M; Denk H; Zatloukal K; Lehrach H; Wierling C
PLoS One; 2014; 9(10):e111006. PubMed ID: 25347188
[TBL] [Abstract][Full Text] [Related]
19. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
[TBL] [Abstract][Full Text] [Related]
20. UPLC-MS-based metabonomic analysis of intervention effects of Da-Huang-Xiao-Shi decoction on ANIT-induced cholestasis.
Zhu G; Feng F
J Ethnopharmacol; 2019 Jun; 238():111860. PubMed ID: 30965080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
